Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Arrowhead Pharmaceuticals, Inc. Transaction History
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
- $100 Billion
- Q4 2024
A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 13,281 shares of ARWR stock, worth $183,543. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,281
Previous 10,725
23.83%
Holding current value
$183,543
Previous $207,000
20.29%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding ARWR
# of Institutions
303Shares Held
95.7MCall Options Held
523KPut Options Held
493K-
Black Rock Inc. New York, NY15.7MShares$217 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$168 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$154 Million3.04% of portfolio
-
State Street Corp Boston, MA6.02MShares$83.1 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$72.3 Million1.89% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $1.46B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...